• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性钙肾结石患者严重成石活性的生化决定因素。

Biochemical determinants of severe lithogenic activity in patients with idiopathic calcium nephrolithiasis.

机构信息

Department of Urology, San Cecilio University Hospital, Granada, Spain.

出版信息

Urology. 2012 Jan;79(1):48-54. doi: 10.1016/j.urology.2011.07.1382. Epub 2011 Sep 9.

DOI:10.1016/j.urology.2011.07.1382
PMID:21908029
Abstract

OBJECTIVE

To analyze the biochemical alterations in plasma and the urine determinants of severe lithogenic activity in patients with idiopathic calcium nephrolithiasis.

METHODS

We performed a cross-sectional study of 120 patients divided into 2 groups: group 1, 60 patients without nephrolithiasis; and group 2, 60 patients with severe and/or recurrent calcium nephrolithiasis. In all patients, a study of renal function, calcium metabolism, and bone remodeling markers, and a study of the lithogenic factors were performed in urine after fasting and in 24-hour urine samples.

RESULTS

We observed greater values for phosphorus in group 1 than in group 2 (P=.03). Also, we found greater values for intact parathyroid hormone (P=.01), osteocalcin (P=.000), and β-crosslaps (P=.000) in group 2 than in group 1. In the 24-hour urine samples, significant differences were found between groups 1 and 2 in calciuria (11.7 vs 17.4 mg/dL; P=.000), citraturia (50.6 vs 33.5 mg/dL; P=.002), calcium/creatinine quotient (0.14 vs 0.20; P=.001), calcium/citrate quotient (0.05 vs 0.13; P=.04), and calcium/creatinine quotient after fasting (0.09 vs 0.16; P=.000).

CONCLUSION

We consider the determinants of severe and/or recurrent calcium lithiasis to be hypercalciuria and hypocitraturia and a calcium/citrate quotient>0.06. As risk markers we can consider phosphatemia<2.9 mg/dL, phosphate/chlorine quotient>35, alkaline phosphatase>80 U/L, intact parathyroid hormone>60 pg/mL, osteocalcin>16 ng/mL, β-crosslaps>0.400 ng/mL, and β-crosslaps/osteocalcin quotient>0.028.

摘要

目的

分析特发性钙肾结石患者血浆生化改变和尿液中严重成石活性的决定因素。

方法

我们进行了一项横断面研究,共纳入 120 名患者,分为 2 组:第 1 组 60 例无肾结石患者;第 2 组 60 例严重和/或复发性钙肾结石患者。所有患者均进行肾功能、钙代谢和骨重塑标志物研究,并在空腹和 24 小时尿液样本中进行成石因素研究。

结果

我们观察到第 1 组的磷值高于第 2 组(P=.03)。此外,我们发现第 2 组的完整甲状旁腺激素(P=.01)、骨钙素(P=.000)和 β-胶原交联(P=.000)值均高于第 1 组。在 24 小时尿液样本中,第 1 组和第 2 组之间的尿钙排泄量(11.7 与 17.4 mg/dL;P=.000)、枸橼酸盐排泄量(50.6 与 33.5 mg/dL;P=.002)、钙/肌酐比值(0.14 与 0.20;P=.001)、钙/枸橼酸盐比值(0.05 与 0.13;P=.04)和空腹后钙/肌酐比值(0.09 与 0.16;P=.000)均有显著差异。

结论

我们认为严重和/或复发性钙结石的决定因素是高钙尿症和低枸橼酸尿症,以及钙/枸橼酸盐比值>0.06。作为风险标志物,我们可以考虑血磷<2.9 mg/dL、磷/氯比值>35、碱性磷酸酶>80 U/L、完整甲状旁腺激素>60 pg/mL、骨钙素>16 ng/mL、β-胶原交联>0.400 ng/mL 和 β-胶原交联/骨钙素比值>0.028。

相似文献

1
Biochemical determinants of severe lithogenic activity in patients with idiopathic calcium nephrolithiasis.特发性钙肾结石患者严重成石活性的生化决定因素。
Urology. 2012 Jan;79(1):48-54. doi: 10.1016/j.urology.2011.07.1382. Epub 2011 Sep 9.
2
Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis.枸橼酸盐和钙:枸橼酸盐比值在钙性肾结石和严重结石形成患者中的重要性。
BJU Int. 2013 Apr;111(4):622-7. doi: 10.1111/j.1464-410X.2012.11292.x. Epub 2012 Jul 3.
3
Association of severe calcium lithogenic activity and bone remodeling markers.严重钙结石形成活性与骨重塑标志物的关联。
Urology. 2013 Jul;82(1):16-21. doi: 10.1016/j.urology.2013.02.035. Epub 2013 Apr 16.
4
Mineral density and bone remodelling markers in patients with calcium lithiasis.钙结石患者的骨密度和骨重建标志物。
BJU Int. 2011 Dec;108(11):1903-8; discussion 1908. doi: 10.1111/j.1464-410X.2011.10167.x. Epub 2011 May 9.
5
Retrospective review of serum and urinary lithogenic risk factors in patients with osteoporosis and osteopenia.骨质疏松症和骨质减少患者血清及尿液结石形成风险因素的回顾性研究。
Urology. 2015 Apr;85(4):782-5. doi: 10.1016/j.urology.2015.01.019.
6
Bone remodeling markers as lithogenic risk factors in patients with osteopenia-osteoporosis.骨重塑标志物作为骨质减少-骨质疏松症患者的结石形成风险因素
Int Urol Nephrol. 2016 Nov;48(11):1777-1781. doi: 10.1007/s11255-016-1361-5. Epub 2016 Jul 4.
7
The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.在骨质减少/骨质疏松患者中,尿钙作为致石因素的重要性。
Int Urol Nephrol. 2015 Mar;47(3):445-9. doi: 10.1007/s11255-015-0918-z. Epub 2015 Feb 5.
8
Calcium and phosphorus metabolism in stable renal transplant recipients.稳定期肾移植受者的钙磷代谢
Exp Clin Transplant. 2007 Dec;5(2):670-2.
9
Prevalence of fasting hypercalciuria associated with increased citraturia in the ambulatory evaluation of nephrolithiasis.在肾结石门诊评估中,与枸橼酸盐尿增加相关的空腹高钙尿症患病率。
J Nephrol. 2005 May-Jun;18(3):262-6.
10
[Sodium excretion in children with lithogenic disorders].[患有结石形成疾病儿童的钠排泄]
Srp Arh Celok Lek. 1998 Sep-Oct;126(9-10):321-6.

引用本文的文献

1
Bone Metabolism Defects in Children With Idiopathic Hypercalciuria: An Update.特发性高钙尿症患儿的骨代谢缺陷:最新进展
Cureus. 2025 Apr 24;17(4):e82931. doi: 10.7759/cureus.82931. eCollection 2025 Apr.
2
Associations between 25-hydroxyvitamin D/calcium/alkaline phosphatase levels and the risk of developing kidney stones: Results from NHANES (2013-2018)-based and Mendelian randomization studies.25-羟基维生素D/钙/碱性磷酸酶水平与肾结石发病风险之间的关联:基于美国国家健康与营养检查调查(2013 - 2018年)及孟德尔随机化研究的结果
Medicine (Baltimore). 2025 Jan 24;104(4):e41323. doi: 10.1097/MD.0000000000041323.
3
How useful is an oral calcium load test for diagnosing recurrent calcium stone formers?
口服钙负荷试验诊断复发性钙结石形成者的作用有多大?
Urolithiasis. 2022 Oct;50(5):577-587. doi: 10.1007/s00240-022-01355-w. Epub 2022 Aug 22.
4
Vitamin D metabolism in dogs with and without hypercalciuric calcium oxalate urolithiasis.患有和未患有高钙尿草酸钙尿路结石的犬类的维生素D代谢
J Vet Intern Med. 2019 Mar;33(2):758-763. doi: 10.1111/jvim.15442. Epub 2019 Mar 9.
5
Bone resorption in dogs with calcium oxalate urolithiasis and idiopathic hypercalciuria.患有草酸钙尿石症和特发性高钙尿症的犬类的骨吸收
Res Vet Sci. 2019 Apr;123:129-134. doi: 10.1016/j.rvsc.2019.01.001. Epub 2019 Jan 4.
6
Does idiopathic hypercalciuria affect bone metabolism during childhood? A prospective case-control study.特发性高钙尿症是否会影响儿童时期的骨代谢?一项前瞻性病例对照研究。
Pediatr Nephrol. 2018 Dec;33(12):2321-2328. doi: 10.1007/s00467-018-4027-y. Epub 2018 Jul 25.
7
The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.在骨质减少/骨质疏松患者中,尿钙作为致石因素的重要性。
Int Urol Nephrol. 2015 Mar;47(3):445-9. doi: 10.1007/s11255-015-0918-z. Epub 2015 Feb 5.
8
Internet program for facilitating dietary modifications limiting kidney stone risk.促进饮食调整以降低肾结石风险的互联网程序。
Can J Urol. 2013 Oct;20(5):6922-6.
9
Kidney stones: a fetal origins hypothesis.肾结石:一个胎儿起源假说。
J Bone Miner Res. 2013 Dec;28(12):2535-9. doi: 10.1002/jbmr.1993.
10
Bone and metabolic markers in women with recurrent calcium stones.复发性钙结石女性的骨骼和代谢标志物
Korean J Urol. 2013 Mar;54(3):177-82. doi: 10.4111/kju.2013.54.3.177. Epub 2013 Mar 15.